J&J raises prices for dozens of drugs

After more than 30 drugmakers ushered in the new year with a wave of price hikes, another pharma giant, Johnson & Johnson, is following suit.

The pharma giant raised the U.S. price of about two dozen drugs Jan. 10, including its psoriasis treatment Stelara and blood thinner Xarelto, Reuters reports.  

Most increases ranged from 6 percent to 7 percent.

J&J said it does not plan to raise prices on any more drugs this year.

Drugmakers kicked off 2019 by raising the prices of more than 250 medications. That total has now almost doubled, with drugmakers hiking prices on nearly 490 drugs by Jan. 10.

Read the full report here.

More articles on pharmacy:
Hospital-owned drug company attracts 12 more health systems
How nurses are becoming integral to pharma marketing: 7 notes
4 tips for managing drug spend from Alameda Health System's Dr. Yi-Chih Peng

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months